POTENTIAL RELEVANCE OF CHANGES IN HEMATOCRIT TO CHANGES IN LIPID PARAMETERS WITH EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
AACE ePoster Library. Lund S. 05/27/16; 131474; 294
Søren Lund
Søren Lund
Login now to access Regular content available to all registered users.
Rate & Comment (0)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies